Avidity Partners Management LP
DALLAS, TX · CIK 1791827 · 13F filing filed 2025-08-14
SEC-registered investment adviser since 2020 · limited partnership
- Assets managed$1.1bn
- Staff9 · 7 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds3 (3 hedge) · $1.1bn gross assets
- Form ADV · 2026-03-31SEC adviser record
- Legal entityAVIDITY PARTNERS MANAGEMENT LP (US)
- Kindhedge funds
- Others nearbyDallas, TX, New York, NY
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Dallas, TX (main office)United States | about 5 |
| New York, NYUnited States | 2 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 1 call positions ($3.2m notional), 0 put positions (— notional) – listed below, not included above.
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| CG ONCOLOGY INC CGON | $39.0m7.82% | Added +519.0k |
| BOSTON SCIENTIFIC CORP BSX | $34.6m6.93% | Reduced -14.2k |
| NATERA INC NTRA | $33.7m6.75% | Added +80.1k |
| DIANTHUS THERAPEUTICS INC DNTH | $32.5m6.51% | Added +22.0k |
| EXACT SCIENCES CORP EXAS | $18.9m3.78% | Added +2.0k |
| TENET HEALTHCARE CORP THC | $18.7m3.74% | Added +34.0k |
| DEXCOM INC DXCM | $18.4m3.68% | Added +30.5k |
| DANAHER CORPORATION DHR | $17.7m3.55% | Added +45.2k |
| HINGE HEALTH INC HNGE | $16.7m3.34% | New |
| INTUITIVE SURGICAL INC ISRG | $14.7m2.95% | New |
| GENMAB A/S GMAB | $13.4m2.69% | New |
| REPLIGEN CORP RGEN | $13.2m2.66% | New |
| THERMO FISHER SCIENTIFIC INC TMO | $12.0m2.41% | Added +14.1k |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $11.6m2.32% | Added +208.5k |
| JADE BIOSCIENCES INC JBIO | $11.3m2.26% | New |
| PHATHOM PHARMACEUTICALS INC PHAT | $10.2m2.05% | Added +264.5k |
| UNITEDHEALTH GROUP INC UNH | $10.0m2.00% | Reduced -18.5k |
| MCKESSON CORP MCK | $9.9m1.98% | New |
| AXSOME THERAPEUTICS INC AXSM | $9.9m1.98% | Added +17.5k |
| CENCORA INC COR | $9.8m1.97% | Reduced -6.5k |
| HEALTHEQUITY INC HQY | $9.6m1.93% | Added +14.0k |
| ENCOMPASS HEALTH CORP EHC | $9.1m1.82% | New |
| REVOLUTION MEDICINES INC RVMD | $8.4m1.69% | Added +15.6k |
| AKERO THERAPEUTICS INC AKRO | $7.2m1.43% | Added +77.0k |
| OMADA HEALTH INC OMDA | $7.1m1.43% | New |
| BEAM THERAPEUTICS INC BEAM | $7.0m1.40% | Reduced -300.1k |
| HUMANA INC HUM | $6.7m1.35% | Reduced -53.4k |
| PERSPECTIVE THERAPEUTICS INC CATX | $6.4m1.28% | Reduced -338.7k |
| ORGANON & CO OGN | $6.2m1.24% | Added +105.0k |
| BRIDGEBIO PHARMA INC BBIO | $6.0m1.21% | Added +65.0k |
| INSMED INC INSM | $5.9m1.19% | Reduced -48.0k |
| MADRIGAL PHARMACEUTICALS INC MDGL | $5.8m1.15% | New |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $5.6m1.12% | Reduced -168.1k |
| CONTEXT THERAPEUTICS INC CNTX | $4.9m0.98% | Added +55 |
| ORUKA THERAPEUTICS INC ORKA | $3.9m0.79% | Unchanged |
| IMMUNIC INC COM | $3.9m0.79% | Added +1.2m |
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $3.8m0.75% | New |
| DOXIMITY INC DOCS | $3.7m0.74% | Reduced -62.5k |
| XENON PHARMACEUTICALS INC XENE | $3.4m0.68% | Reduced -121.1k |
| VERONA PHARMA PLC VRNA | $3.2m0.64% | New |
| UNIQURE NV QURE | $2.9m0.58% | Reduced -129.2k |
| APOGEE THERAPEUTICS INC COM | $2.8m0.57% | New |
| SOLENO THERAPEUTICS INC SLNO | $2.7m0.54% | Unchanged |
| CARDINAL HEALTH INC CAH | $2.5m0.51% | New |
| ARS PHARMACEUTICALS INC SPRY | $2.4m0.49% | New |
| KEZAR LIFE SCIENCES INC KZR | $2.3m0.46% | Unchanged |
| INTELLIA THERAPEUTICS INC NTLA | $2.2m0.44% | New |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX | $1.8m0.37% | New |
| ARVINAS INC ARVN | $1.8m0.36% | Reduced -170.0k |
| SYNDAX PHARMACEUTICALS INC SNDX | $1.4m0.28% | Reduced -775.0k |
| SCYNEXIS INC COM NEW | $829.3k0.17% | Unchanged |
| KARYOPHARM THERAPEUTICS INC KPTI | $580.0k0.12% | Unchanged |
| ALTIMMUNE INC ALT | $406.4k0.08% | New |
| ENLIVEN THERAPEUTICS INC ELVN | $226.7k0.05% | Unchanged |
| REVIVA PHARMACEUTCLS HLDGS I COM | $52.6k0.01% | Unchanged |
Sold out since Q1 2025
| Security | Value then |
|---|---|
| REGENERON PHARMACEUTICALS REGN | $16.1m25.4k shares |
| GLAUKOS CORP GKOS | $13.2m134.0k shares |
| JAZZ PHARMACEUTICALS PLC JAZZ | $9.9m80.0k shares |
| NEUROCRINE BIOSCIENCES INC NBIX | $9.5m85.7k shares |
| SPDR SER TR XBI | $7.6m94.0k shares |
| CENTESSA PHARMACEUTICALS PLC | $7.6m529.0k shares |
| AVANTOR INC AVTR | $7.3m453.0k shares |
| IDEAYA BIOSCIENCES INC IDYA | $7.3m445.0k shares |
| JANUX THERAPEUTICS INC JANX | $7.0m258.0k shares |
| BLUEPRINT MEDICINES CORP BPMC | $6.1m68.5k shares |
| UNITED THERAPEUTICS CORP DEL UTHR | $5.2m16.8k shares |
| BRUKER CORP BRKR | $4.8m115.0k shares |
| BIOHAVEN LTD BHVN | $3.5m145.0k shares |
| ACADIA PHARMACEUTICALS INC ACAD | $2.8m169.0k shares |
| ROYALTY PHARMA PLC RPRX | $2.7m87.0k shares |
| CAPRICOR THERAPEUTICS INC CAPR | $2.3m239.0k shares |
| LEXEO THERAPEUTICS INC LXEO | $2.2m645.0k shares |
| VERA THERAPEUTICS INC VERA | $2.2m91.0k shares |
| REGENXBIO INC RGNX | $1.9m260.0k shares |
| IONIS PHARMACEUTICALS INC IONS | $1.8m60.0k shares |
| MIRUM PHARMACEUTICALS INC MIRM | $1.8m40.0k shares |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $1.4m68.0k shares |
| AGILON HEALTH INC | $1.3m305.1k shares |
| VAXCYTE INC PCVX | $868.5k23.0k shares |
| HYPERFINE INC HYPR | $159.1k222.2k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SYNDAX PHARMACEUTICALS INC SNDX · Call | $3.2m340.0k shares | Reduced |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| IMMUNIC INC 13G · filed 2026-04-17 | 9.9% |
| CONTEXT THERAPEUTICS INC CNTX · 13G · filed 2026-05-12 | 8.7%≈ $4.6m |
| PERSPECTIVE THERAPEUTICS INC CATX · 13G · filed 2026-03-10 | 5.3%≈ $20.6m |